Page last updated: 2024-11-08

desoxycorticosterone acetate and Cerebral Small Vessel Diseases

desoxycorticosterone acetate has been researched along with Cerebral Small Vessel Diseases in 2 studies

Desoxycorticosterone Acetate: The 21-acetate derivative of desoxycorticosterone.

Cerebral Small Vessel Diseases: Pathological processes or diseases where cerebral MICROVESSELS show abnormalities. They are often associated with aging, hypertension and risk factors for lacunar infarcts (see LACUNAR INFARCTION); LEUKOARAIOSIS; and CEREBRAL HEMORRHAGE.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Guy, R2
Volkman, R1
Wilczynski, E1
Yagil, C2
Yagil, Y2
Findler, M1
Auriel, E1
Nevo, U1
Offen, D2
Herman, S1
Benyamini, H1
Ben-Zur, T1
Kobo, H1
Pasmanik-Chor, M1
Yaacobi, D1
Barel, E1

Other Studies

2 other studies available for desoxycorticosterone acetate and Cerebral Small Vessel Diseases

ArticleYear
A Novel Rodent Model of Hypertensive Cerebral Small Vessel Disease with White Matter Hyperintensities and Peripheral Oxidative Stress.
    International journal of molecular sciences, 2022, May-25, Volume: 23, Issue:11

    Topics: Animals; Cerebral Hemorrhage; Cerebral Small Vessel Diseases; Desoxycorticosterone Acetate; Hyperten

2022
Mesenchymal Stem Cell-Derived Extracellular Vesicles as Proposed Therapy in a Rat Model of Cerebral Small Vessel Disease.
    International journal of molecular sciences, 2022, Sep-23, Volume: 23, Issue:19

    Topics: Animals; Anti-Inflammatory Agents; Cerebral Small Vessel Diseases; Desoxycorticosterone Acetate; Dis

2022